Glycemic effects of simvastatin: Where do we stand?
ABSTRACT In clinical practice, simvastatin is usually used in the treatment of dyslipidemia patients and those at risk of or with established cardiovascular disease. However, previous studies have shown that simvastatin has the potential to affect glycemic parameters as it reportedly reduced insulin...
Main Authors: | Nor Razida Razali, Hasniza Zaman Huri, Luqman Ibrahim, Shireene Ratna Vethakkan, Bashar Mudhaffar Abdullah |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2018-06-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000100403&lng=en&tlng=en |
Similar Items
-
Is insulin topical gel better than simvastatin topical gel in full thickness wound?
by: Timotius Hansen Arista, et al.
Published: (2019-03-01) -
Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?
by: C. Bulcão, et al.
Published: (2007-02-01) -
Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?
by: C. Bulcão, et al. -
The modulatory effects of simvastatin, a HMG CoA reductase inhibitor, on insulin release from isolated porcine pancreatic islets of Langerhans.
Published: (2010) -
Short-term insulin therapy at the time of diagnosis of Type 2 diabetes leads to better glycemic control and improved beta cell function
by: Siddharth Madnani, et al.
Published: (2019-01-01)